| Application no. and date | 18722948.9 (espacenet) (Federated) (European Patent Register), 20180502 | | Patent/reg. no. and date | DK/EP 3619199, 20210707 | | Publication date | 20200311 | | Priority no. and date | WO PCT/EP2017/060451, 20170503 | | EP pub. no. and date |
EP 3619199 20200311 | | Effective date | | | Applicant/owner | Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91
4123 Allschwil, CH | | Applicant ref. no. | P77381DK01 | | Inventor | DÖRRWÄCHTER, Patric, c/o Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil, CH,
SCHMIDT, Gunther, c/o Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07D 249/06 (2006.01) | | Title | FREMSTILLING AF 2-([1,2,3]TRIAZOL-2-YL)-BENZOESYREDERIVATER | | Int. application no. | EP2018061172 | | Int. publication no. | WO2018202689 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
